Michael Amoroso
Chief Executive Officer bij PRECISION BIOSCIENCES, INC.
Vermogen: 873 863 $ op 31-03-2024
Actieve functies van Michael Amoroso
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ABEONA THERAPEUTICS INC. | Chairman | 14-10-2021 | - |
Director/Board Member | 19-03-2021 | 14-10-2021 | |
Chief Executive Officer | 19-03-2021 | 14-10-2021 | |
Chief Operating Officer | 01-11-2020 | 19-03-2021 | |
Corporate Officer/Principal | 09-07-2020 | 01-11-2020 | |
President | 19-03-2021 | 14-10-2021 | |
PRECISION BIOSCIENCES, INC. | Director/Board Member | 15-10-2021 | - |
Chief Executive Officer | 15-10-2021 | - | |
President | 15-10-2021 | - |
Loopbaan van Michael Amoroso
Eerdere bekende functies van Michael Amoroso
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
KITE PHARMA INC | Corporate Officer/Principal | 01-08-2018 | 01-01-2020 |
Opleiding van Michael Amoroso
Rider University | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ABEONA THERAPEUTICS INC. | Health Technology |
PRECISION BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Beurs
- Insiders
- Michael Amoroso
- Ervaring